[COVID-19 Vaccination in Asthma Patients Treated with Biologicals - Statement of the Austrian
Society of Pneumology and German Respiratory Society]. - Abstract - Europe PMC Sign in …

Background Vaccination is vital for achieving population immunity to severe acute
respiratory syndrome coronavirus 2, but vaccination hesitancy presents a threat to achieving …

Background: COVID-19 vaccination has been recommended for severe asthmatics. We
aimed to evaluate the safety, tolerability, and impact on disease control and patient's quality …

Objective Both patients and physicians may be hesitant toward vaccination in patients with
asthma, which may result in lower vaccine uptake. The aim of this work was to investigate …

Introduction There is ongoing debate regarding the role of severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) infection in asthma exacerbation, and its long-term …

COVID-19 vaccines are important for the primary prevention of SARSCov-2 infection. In
exceptional cases, its administration can compensate the preexisting pathologies, in …

Those left out of early vaccination plans include people with well controlled asthma who take
regular inhaled steroids, such as budesonide, and who would normally receive a request to …

Immune modulation is a key therapeutic approach for allergic diseases, asthma and
autoimmunity. It can be achieved in an antigen‐specific manner via allergen immunotherapy …

Background Few studies have reported the clinical features of patients with coronavirus
disease 2019 (COVID-19) who were treated with biologics for severe asthma (SA). Objective …

Background: After the beginning and during the worldwide pandemic caused by the severe
acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), patients with allergic and …